EAM
Eventide Asset Management Portfolio holdings
AUM
$6.08B
1-Year Est. Return
64.4%
1 Year Est. Return
+64.4%
AUM
$5.71B
AUM Growth
+$688M
(+14%)
Holding
257
Top Buys
| 1 | +$28.9M | |
| 2 | +$28.5M | |
| 3 | +$27.8M | |
| 4 |
Verisk Analytics
VRSK
|
+$26M |
| 5 |
Lam Research
LRCX
|
+$25.3M |
Top Sells
| 1 | +$48.8M | |
| 2 | +$44.8M | |
| 3 | +$36.5M | |
| 4 |
Evolent Health
EVH
|
+$22.4M |
| 5 |
Inspire Medical Systems
INSP
|
+$19.4M |
Sector Composition
| 1 | Healthcare | 37.06% |
| 2 | Technology | 18.81% |
| 3 | Industrials | 18.23% |
| 4 | Consumer Discretionary | 7.45% |
| 5 | Utilities | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
EXL Service
EXLS
$6.31B
| $17.3M | 0.3% |
394,930
-2,130
|
|
||
102
Rockwell Automation
ROK
$42.4B
| $16.9M | 0.3% |
50,982
+787
|
|
||
103
BridgeBio Pharma
BBIO
$12.9B
| $16.6M | 0.29% |
384,231
-147,961
|
|
||
104
Equity Residential
EQR
$22.7B
| $16.6M | 0.29% |
206,835
-183,645
|
|
||
105
Disc Medicine
IRON
$3.41B
| $16.3M | 0.29% |
308,030
+126,212
|
|
||
106
IDEAYA Biosciences
IDYA
$2.83B
| $16.2M | 0.28% |
771,844
|
|
||
107
Acadia Pharmaceuticals
ACAD
$4.07B
| $15.7M | 0.28% |
728,437
-124,408
|
|
||
108
Xylem
XYL
$34.8B
| $14.5M | 0.25% |
112,302
+1,386
|
|
||
109
Fair Isaac
FICO
$41.4B
| $14.3M | 0.25% |
7,842
+8
|
|
||
110
Broadcom
AVGO
$1.61T
| $14.2M | 0.25% |
50,971
+19,384
|
|
||
111
AvalonBay Communities
AVB
$25.2B
| $14M | 0.24% |
+68,675
|
|
||
112
Revolution Medicines
RVMD
$13.1B
| $13.7M | 0.24% |
372,229
|
|
||
113
McCormick & Company Non-Voting
MKC
$17.6B
| $13.6M | 0.24% |
179,650
+8,599
|
|
||
114
United Therapeutics
UTHR
$20.2B
| $13.6M | 0.24% |
47,241
|
|
||
115
American Express
AXP
$246B
| $13.3M | 0.23% |
40,710
+15,448
|
|
||
116
Syndax Pharmaceuticals
SNDX
$1.46B
| $13.2M | 0.23% |
1,414,081
+236,019
|
|
||
117
Pool Corp
POOL
$9.04B
| $11.8M | 0.21% |
40,390
+1,471
|
|
||
118
Intuit
INTU
$186B
| $11.8M | 0.21% |
14,796
+2,365
|
|
||
|
MTSR
119
Metsera Inc
MTSR
$7.43B
| $11.3M | 0.2% |
396,160
+146,160
|
|
||
120
Home Depot
HD
$360B
| $11.2M | 0.2% |
29,203
+6,315
|
|
||
121
Bruker
BRKR
$6.34B
| $11.2M | 0.2% |
272,324
+135,924
|
|
||
122
S&P Global
SPGI
$150B
| $11M | 0.19% |
20,700
+2,165
|
|
||
123
Avidity Biosciences
RNA
$10.7B
| $10.7M | 0.19% |
375,924
|
|
||
124
Akero Therapeutics
AKRO
$4.47B
| $10.7M | 0.19% |
200,000
-534
|
|
||
125
Linde
LIN
$198B
| $10.6M | 0.19% |
22,460
+283
|
|